Nevertheless, our study highlights the effectiveness of simultaneous genomic and transcriptomic profiles of HR+/HER2-BC at the single-cell level, with particular focus on the migratory SC-f tumor subtype in relation to EGFR genomic aberration and the interplay between CAFs. The gene discussed is ERBB2; the disease is breast cancer.